Pushing the Limits of Lifespan, from Innovation to Commercialization

May 7, 2015

Hamilton Brook Smith Reynolds is pleased to be a sponsor of the MIT Enterprise Forum of Cambridge. The forum's Innovation Series event, "Pushing the Limits of Lifespan, from Innovation to Commercialization," was held on Thursday, May 7, 2015, from 5:30 - 8:00 p.m. at The Broad Institute in Cambridge, MA.

 

MIT Enterprise Forum Event Description

MIT Enterprise ForumLife extending technologies and research are evolving exponentially, from induced pluripotent stem cells (IPS), pharmacogenomics and embedded technologies to naturally derived alternative therapies and holistic approaches. In this climate, investors and consumers are left to perform high-stakes due diligence that can influence both the financial success of a company and also one’s individual health.

Join us for an event that brings together both internationally renowned researchers and leading life science investors for a conversation that explores the fascinating field of life extension, its potential for monetization and role in challenging humanity’s greatest adversary, mortality itself.

Moderator:

  • Carol Massar, Co-host of “Taking Stock” on Bloomberg Radio, Chief National Correspondent for Bloomberg Television


The panelists:

  • Sanjiv Chopra, Professor of Medicine at Harvard Medical School
  • Aubrey de Grey, Chief Science Officer & Co-founder of the SENS Research Foundation
  • George Q. Daley, Harvard University, HHMI and Children’s Hospital Boston
  • Marian Nakada, Vice President Venture Investments, Johnson & Johnson Innovation
  • Amy Schulman, Partner, Polaris Partners & CEO of Arsia Therapeutics

 

Agenda
5:30 – 6:00 p.m. Registration & Networking
6:00 – 8:00 p.m. Program
8:00 – 9:00 p.m. After party and networking

 

For more information, please visit the MIT Enterprise Forum of Cambridge website.

About

May 7, 2015

Hamilton Brook Smith Reynolds is pleased to be a sponsor of the MIT Enterprise Forum of Cambridge. The forum's Innovation Series event, "Pushing the Limits of Lifespan, from Innovation to Commercialization," was held on Thursday, May 7, 2015, from 5:30 - 8:00 p.m. at The Broad Institute in Cambridge, MA.

 

MIT Enterprise Forum Event Description

MIT Enterprise ForumLife extending technologies and research are evolving exponentially, from induced pluripotent stem cells (IPS), pharmacogenomics and embedded technologies to naturally derived alternative therapies and holistic approaches. In this climate, investors and consumers are left to perform high-stakes due diligence that can influence both the financial success of a company and also one’s individual health.

Join us for an event that brings together both internationally renowned researchers and leading life science investors for a conversation that explores the fascinating field of life extension, its potential for monetization and role in challenging humanity’s greatest adversary, mortality itself.

Moderator:

  • Carol Massar, Co-host of “Taking Stock” on Bloomberg Radio, Chief National Correspondent for Bloomberg Television


The panelists:

  • Sanjiv Chopra, Professor of Medicine at Harvard Medical School
  • Aubrey de Grey, Chief Science Officer & Co-founder of the SENS Research Foundation
  • George Q. Daley, Harvard University, HHMI and Children’s Hospital Boston
  • Marian Nakada, Vice President Venture Investments, Johnson & Johnson Innovation
  • Amy Schulman, Partner, Polaris Partners & CEO of Arsia Therapeutics

 

Agenda
5:30 – 6:00 p.m. Registration & Networking
6:00 – 8:00 p.m. Program
8:00 – 9:00 p.m. After party and networking

 

For more information, please visit the MIT Enterprise Forum of Cambridge website.

Back to the Top